Products for Research Use Only
RegisterLogin

Obiltoxaximab

CAT: 0804-HY-P9932-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P9932-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Obiltoxaximab (ETI 204) is the second and potent anti-protective antigen (PA) monoclonal antibody with immunogenicity. Obiltoxaximab plays a central role in anthrax toxin assembly and target cell intoxication, promoting survival, and inhibiting bacterial spread to the periphery in animal models. Obiltoxaximab can be used in the research of inhalational anthrax, bacteremia and toxemia[1][2][3][4].
CAS Number
1351337-07-9
Product Name Alternative
ETI 204
UNSPSC
12352203
Target
Bacterial
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/obiltoxaximab.html
Purity
99.06
Solubility
H2O
Smiles
[Obiltoxaximab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Nagy CF, et al. Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. Clin Transl Sci. 2017 Jan;10 (1) :12-19.|[2]Yamamoto BJ, et al. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax. Antimicrob Agents Chemother. 2016 Sep 23;60 (10) :5796-805.|[3]Hou A W, et al. Obiltoxaximab: adding to the treatment arsenal for Bacillus anthracis infection[J]. Annals of Pharmacotherapy, 2017, 51 (10) : 908-913.|[4]Yamamoto B J, et al. Obiltoxaximab prevents disseminated Bacillus anthracis infection and improves survival during pre-and postexposure prophylaxis in animal models of inhalational anthrax[J]. Antimicrobial agents and chemotherapy, 2016, 60 (10) : 5796-5805.|[5]Biron B, et al. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax[J]. Antimicrob Agents Chemother. 2015 Apr;59 (4) :2206-14.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
T78290-01Obiltoxaximab
CBA1065-01Obiltoxaximab Biosimilar
GTR18399102-01Obiltoxaximab Antibody
DN898018Obiltoxaximab ELISA Kit
MBS1564089-01Research Grade Obiltoxaximab
E55B0722Obiltoxaximab (Reference antibody)
GTR18780206-01(Obiltoxaximab) Biosimilar Reference Antibody
ICH5306-50mgObiltoxaximab Biosimilar - Research Grade
GTR18697470-01Obiltoxaximab Chimeric Monoclonal Antibody
592053Obiltoxaximab (Anthrax protective antigen)

Popular Products